bioXXmed Aktie

Watchlist T5O0 WKN A4BGGE ISIN DE000A4BGGE4
- -
-

Was macht bioXXmed?

Unternehmensprofil
Unternehmensprofil

bioXXmed AG is a biotechnology company, which engages in the research and development of therapies to treat cause of diseases. The company provides treatment options in dermatology, cardiology and angiology, urology, and oncology. Its products and pipeline include DermaPro, CardioClean, Cancer T17-n, and Utisept. The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany.

Chart der bioXXmed Aktie

Charttool öffnen